Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 1/20 | 0.42 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.42 |
| ▸ | PI4KA | P42356 | 1/20 | 0.38 |
| ▸ | PI4K2B | Q8TCG2 | 1/20 | 0.38 |
| ▸ | PI4K2A | Q9BTU6 | 1/20 | 0.38 |
| ▸ | PI4KB | Q9UBF8 | 1/20 | 0.38 |
| ▸ | NT5E | P21589 | 7/20 | 0.38 |
| ▸ | TMEM97 | Q5BJF2 | 2/20 | 0.36 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.36 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.36 |
| ▸ | HTR2B | P41595 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | IDH1 | O75874 | 1/20 | 0.35 |
| ▸ | KCNN3 | Q9UGI6 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21839818 | 1.00 | ADORA2A (0.42) | ADORA2AADORA2BPI4KAPI4K2BPI4K2A | |
| SCHEMBL21839816 | 1.00 | ADORA2A (0.42) | ADORA2AADORA2BPI4KAPI4K2BPI4K2A | |
| SCHEMBL21839808 | 0.87 | NT5E (0.37) | ADORA2AADORA2BNT5EIDH1 | |
| SCHEMBL21839807 | 0.87 | NT5E (0.37) | ADORA2AADORA2BNT5EIDH1 | |
| SCHEMBL23915598 | 0.86 | NT5E (0.48) | NT5ETMEM97OPRK1SIGMAR1HTR2B | |
| SCHEMBL21882964 | 0.86 | NT5E (0.48) | NT5ETMEM97OPRK1SIGMAR1HTR2B | |
| SCHEMBL21839619 | 0.86 | NT5E (0.48) | NT5ETMEM97OPRK1SIGMAR1HTR2B | |
| SCHEMBL21882842 | 0.86 | NT5E (0.48) | NT5ETMEM97OPRK1SIGMAR1HTR2B | |
| SCHEMBL21839617 | 0.86 | NT5E (0.48) | NT5ETMEM97OPRK1SIGMAR1HTR2B | |
| SCHEMBL21839740 | 0.86 | NT5E (0.50) | NT5E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200115404-A1 | CD73 INHIBITORS AND USES THEREOF | PELOTON THERAPEUTICS INC. | 2020-04-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200115404-A1 | CD73 INHIBITORS AND USES THEREOF | ENTPD5, ENTPD1, NT5E | ADORA2A 11/4885ADORA2B 51/4885PI4KA 2028/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.